CASE STUDY #2 BENEFICENCE & NON-MALEFICENCE Sandra Brownstein, PharmD Marianne McCarthy, PhD, GNP Sue Sisley, MD Lori Waldberg, LCSW.

Slides:



Advertisements
Similar presentations
S OCIAL W ORK IN M ENTAL H EALTH S ETTINGS M ENDOCINO C OLLEGE HUS 170 – I NTRO TO S OCIAL W ORK P REPARED BY A LESE J ENKINS, LCSW – M ARCH 2013.
Advertisements

CASE STUDY #1 AUTONOMY, CAPACITY, & DUTY TO REPORT Faustina Dannenfelser Joanne Gurin, MD Emily Kile, Esq. Roy Yaari, MD.
Deepa Patel Doctor of Pharmacy Candidate, 2012 Mercer COPHS Presented on July 22, 2011.
Value of information An innovative approach to prioritizing comparative effectiveness research AHRQ Annual Meeting September 29, 2010.
Heart and Mind Connections: Integrated Strategies for Greater Health Presentation to Senior Leadership.
Arthur E. Kelley, MD Medical Director, Partnership for Community Care (CCNC) Psychiatric Consultant, Cornerstone Healthcare, High Point, NC.
The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 8 Medication for Mental Disorders.
Heart Disease Map.
© 2012 Chevron Healthy Heart Program Cholesterol Presenter’s Name and Title Location and Date.
Criteria for Psychiatric Symptoms in Alzheimer’s Disease Clinical Trials Jeffrey L. Cummings, M.D. Alzheimer’s Disease Center UCLA School of Medicine FDA.
Prescreening ä To optimize safety ä To permit the development of a sound and effective exercise prescription.
Lookback Module: What you should know 2012 National Conference on Health Statistics Monitoring Health Care Reform through Provider-based Surveys: New Initiatives.
Primary Care Psychology Lisa K. Kearney, Ph.D. Primary Care Psychologist South Texas Veterans Health Care System.
Major Depressive Disorder Presenting Complaints
How to Utilize Your Pharmacist In the Inpatient/Hospital Setting Julie Dopheide, PharmD, BCPP Associate Professor USC School of Pharmacy
Anxiety Arthritis Asthma Atrial Fibrillation Bone Marrow Transplantation BPH Breast Cancer Colon Cancer Coronary Artery Disease Depression Diabetes End.
Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.
Implementing pharmacogenetics with CIPHER™ Personalized Medicine Program Property of PGxl Laboratories Kristen K. Reynolds, PhD VP Laboratory Operations.
SURVIVING CANCER. IMPACT 0f cancer on : Psychological functioning – quality of life Role of psychological variables in cancer risk & survival.
New guidelines for CABG
HONEY “ATTILA” SHAW ZACH “SAC ATTACK” SEELYE BiPoLaR dIsOrDeR.
Talking Points for Managers Community Initiative on Depression Mid-America Coalition on Health Care.
Public Health. CVDDiabetesCancer Antibiotic Resistance.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
Pharmacist Assisted Management of Complex Psychiatric Patients in Primary Care Casey Gallimore, PharmD, Assistant Professor of Pharmacy Ken Kushner, M.A.,
Chapter 15 Adolescent Nutrition: Conditions and Interventions
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
L.A. Care Health Plan Behavioral Health Support Services E.E. Lazarou, MD, MS, RD Health Integrated.
Chapter 14: Anxiety & Depression in the Older Adult.
Electroconvulsive Therapy Review the outline in notes.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Click to edit Master subtitle style Aetna Behavioral Health Depression Initiatives June 2006.
Depressive Disorders and Cardiovascular Medicine Lawson Wulsin, MD Copyright © World Psychiatric Association.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Managing Exercise in Persons with Multiple Chronic Conditions Chapter 04.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
3 Revolutions in Psychology - Psychiatry Psychotherapeutic Drugs.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Polypill x Aspirin Project Groups 3 and 4
MIAMI: MIRECC Initiative on Antipsychotic Management Improvement Metabolic Monitoring and Management of Antipsychotic Medication.
3 Revolutions in Psychology - Psychiatry Psychotherapeutic Drugs.
The Many Moods of Heart Failure Sue Wingate PhD, RN Nurse Practitioner Gaithersburg MD.
The Role of Health Information Technology in Implementing Disease Management Programs Donald F. Wilson, MD Medical Director Quality Insights of Pennsylvania.
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
Waiting for the Psychiatry Consult Treatment of Suspected Bipolar Disorder in the FM Office Spring 2008 Karen S. Blackman, M.D., Department of Family Medicine,
HORMONE REPLACEMENT THERAPY (HRT) Evidence-based Guidelines Dr Mahdy El- Mazzahy Damietta general Hospital 7 th International Annual Congress “Alexandria”
Joint reporting from Hill Physicians and Sutter Independent Physicians 1.
Ch. 19 S. 5 : Biological Therapy
Hypertension guidelines What’s all the controversy about 2015
A middle-aged man is chronically preoccupied with his health
Postpartum Depression
Recognizing Your Risk for Cardiovascular Disease
PSY 6670 Diagnosis & Treatment Planning Lecture 4 : Schizophrenia Spectrum Disorders Treatment Planning Joel Fairbanks, Ph.D.
The Comprehensive Major Depressive Disorder Care Team
Author: Michael Jibson, M.D., Ph.D., 2009
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Diabetes and Psychiatric Disorders: Can they Co-exist?
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
What It Is and Why It Matters
Cardiac Issues: Atrial fibrillation, Pacemakers, Stents, and Rehab
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
New Approaches to Insomnia Management: Impact on Clinical Practice
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Communicating With Your Patients About Major Depressive Disorder
2008 Behavioral Health Symposium
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Part 4 This slide reviews recommendations for antiplatelet therapy from the 2015 ADA guidelines. Refer to source document for full recommendations, including.
Presentation transcript:

CASE STUDY #2 BENEFICENCE & NON-MALEFICENCE Sandra Brownstein, PharmD Marianne McCarthy, PhD, GNP Sue Sisley, MD Lori Waldberg, LCSW

CASE #2 CD, 76 yo widowed female with severe chronic paranoid schizophrenia along with major depression (schizoaffective disorder) Presents to office with son, who has concerns about treatment regimen Has developed several new medical conditions prompting new management options

CASE #2 (cont.) New conditions include: Diabetes Coronary artery disease Hyperlipidemia Essential tremor Uterine cancer Hypothyroidism

CASE #2 (cont.) Has been on lithium for decades Primary care physician (PCP) and consultants have recommended: –Thiazide diuretic –Anti-platelet agent –Diabetes medication –Cholesterol medication –Thyroid replacement –Anti-tremor medication (beta-blocker) –Total hysterectomy

CASE 2 – QUESTION #1 CD is incompetent 1.TRUE 2.FALSE

CASE 2 – QUESTION #2 Only a psychiatrist can assess CD’s capacity to make decisions regarding her medical care 1.TRUE 2.FALSE

CASE 2 – QUESTION #3 Only a psychiatrist can assess CD’s capacity to make decisions regarding her psychiatric care 1.TRUE 2.FALSE

CASE 2 – QUESTION #4 Goals of care questions should include: 1.Adherence/compliance concerns 2.Beneficial effects of medications/surgery 3.Financial cost of treatments 4.Side effects of medications

CASE 2 – QUESTION #5 Potential complications of the new recommendations include: 1.Drug-disease interactions 2.Drug-drug interactions 3.Peri-operative complications 4.All of the above

CASE 2 – QUESTION #6 The psychiatric treatment option with the smallest side effect burden is: 1.Anti-depressant medication 2.Anti-psychotic medication 3.Electro-convulsive therapy 4.Mood stabilizer medication

CASE 2 – QUESTION #7 The medical treatment option with the smallest side effect burden is: 1.Cholesterol medication 2.Diabetes medication 3.Diuretic 4.Surgery 5.Tremor medication

CASE 2 – QUESTION #8 CD’s most likely cause of death will be: 1.Cerebrovascular accident (stroke) 2.Coronary artery disease (heart attack) 3.Schizophrenia (accident/homicide/suicide) 4.Uterine cancer

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.